Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.47 |
| ▸ | TTR | P02766 | 1/20 | 0.47 |
| ▸ | P4HA1 | P13674 | 2/20 | 0.44 |
| ▸ | P4HTM | Q9NXG6 | 2/20 | 0.44 |
| ▸ | MIF | P14174 | 1/20 | 0.44 |
| ▸ | MGAM | O43451 | 1/20 | 0.42 |
| ▸ | TPMT | P51580 | 1/20 | 0.40 |
| ▸ | LDHA | P00338 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | GABRP | O00591 | 1/20 | 0.38 |
| ▸ | GABRD | O14764 | 1/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.38 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.38 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.38 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.38 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29565006 | 1.00 | HCAR2 (0.47) | HCAR2POLBNAPRTTTRP4HA1 | |
| Hydrochloric Acid SCHEMBL2704937 | 0.98 | HCAR2 (0.46) | HCAR2POLBNAPRTTTRP4HA1 | |
| Hydrazine SCHEMBL27966259 | 0.96 | HCAR2 (0.44) | HCAR2POLBNAPRTTTRP4HA1 | |
| SCHEMBL1809522 | 0.84 | NAPRT (0.38) | NAPRTALDH1A1LMNAKMT2AGAA | |
| SCHEMBL9192729 | 0.82 | ALDH1A1 (0.39) | ALDH1A1MEN1LMNAKMT2AGAA | |
| SCHEMBL232290 | 0.79 | HCAR2 (0.50) | HCAR2NAPRTTTRP4HA1P4HTM | |
| SCHEMBL487368 | 0.79 | HCAR2 (0.50) | HCAR2POLBNAPRTTTRP4HA1 | |
| SCHEMBL30792836 | 0.79 | HCAR2 (0.50) | HCAR2POLBNAPRTTTRP4HA1 | |
| SCHEMBL29365646 | 0.79 | HCAR2 (0.50) | HCAR2NAPRTTTRP4HA1P4HTM | |
| SCHEMBL8926986 | 0.78 | ALDH1A1 (0.36) | POLBALDH1A1LMNAGAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 527 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024257116-A1 | NOVEL POLYMORPHIC FORMS OF ASCIMINIB AND ITS PHARMACEUTICAL SALTS THEREOF | NATCO PHARMA LIMITED (IN) | 2024-12-19 | — | — | WO | claimed |
| CN-114149409-B | (hetero) aryl amide compound with protein kinase inhibition activity | 中国药科大学 | 2024-03-22 | — | — | CN | claimed |
| CN-114149409-A | (hetero) aryl amide compound with protein kinase inhibitory activity | 中国药科大学 | 2022-03-08 | — | — | CN | claimed |
| CN-109212051-B | Gas chromatography-mass spectrometry combined method for determining nine trace amounts of halogenated nicotinic acid in drinking water | 丁立平 | 2021-11-19 | — | — | CN | claimed |
| CN-109212051-A | The gas chromatography-mass spectrometry of nine kinds of halogenated niacin of trace in a kind of measurement drinking water | 丁立平 | 2019-01-15 | — | — | CN | claimed |
| US-20260078124-A1 | METHODS OF PREPARING ERGOLINE ANALOGS | UNIV CALIFORNIA (US) | 2026-03-19 | — | — | US | disclosed |
| EP-4646402-A1 | GPR35 MODULATORS | ThirtyFiveBio Limited (GB) | 2025-11-12 | — | — | EP | disclosed |
| US-20250313560-A1 | Novel bicyclic benzylamido pyridine derivatives as SOS1 inhibitors | BOEHRINGER INGELHEIM INT (DE) | 2025-10-09 | — | — | US | disclosed |
| EP-4566608-A2 | THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION | Gilead Sciences, Inc. (US) | 2025-06-11 | — | — | EP | disclosed |
| US-20250179102-A1 | THERAPEUTICS COMPOUNDS FOR HIV VIRUS INFECTION | GILEAD SCIENCES, INC. | 2025-06-05 | — | — | US | disclosed |
| US-20250179032-A1 | HETEROCYCLIC INHIBITORS OF GLUT9 FOR TREATMENT OF DISEASE | HORIZON THERAPEUTICS IRELAND DAC (IE) | 2025-06-05 | — | — | US | disclosed |
| EP-4440702-B1 | THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION | GILEAD SCIENCES INC (US) | 2025-05-21 | — | — | EP | disclosed |
| US-4508907-A | 2,3-Dichloro-5-trichloromethylpyridine | IMPERIAL CHEMICAL INDUSTRIES, PLC (GB) | 1985-04-02 | — | — | US | disclosed |
| EP-0107866-A2 | Trihalomethylpyridine compounds | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-05-09 | — | — | EP | disclosed |
| US-4324627-A | CHLORINATION OF 3-METHYLPYRIDINE UNDER INFLUENCE OF ULTRA VIOLET LIGHT | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1982-04-13 | — | — | US | disclosed |
| US-4317913-A | Herbicidal pyridine compounds | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1982-03-02 | — | — | US | disclosed |
| EP-0028870-A1 | Phenoxypyridine compound | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1981-05-20 | — | — | EP | disclosed |
| EP-0021453-A2 | 2-Chloro-5-trichloromethylpyridine | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1981-01-07 | — | — | EP | disclosed |
| EP-0001473-A2 | Herbicidal halogenomethyl--pyridyloxy-phenoxy-alkanecarboxylic acids and derivatives, and processes of controlling unwanted plants therewith | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1979-04-18 | — | — | EP | disclosed |
| WO-1979000094-A1 | HERBICIDAL PYRIDINE COMPOUNDS | ICI LTD (GB) | 1979-03-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250179102-A1 | THERAPEUTICS COMPOUNDS FOR HIV VIRUS INFECTION | CD4, HAVCR2, MAVS | HCAR2 4069/4885POLB 1081/4885NAPRT 1493/4885 |
| US-20250179032-A1 | HETEROCYCLIC INHIBITORS OF GLUT9 FOR TREATMENT OF DISEASE | SLC2A9, SLC2A1, SLC2A8 | HCAR2 96/4885POLB 4712/4885NAPRT 143/4885 |
| US-20260078124-A1 | METHODS OF PREPARING ERGOLINE ANALOGS | HTR1A, HTR2A, HTR7 | HCAR2 397/4885POLB 4159/4885NAPRT 2124/4885 |
| US-20250313560-A1 | Novel bicyclic benzylamido pyridine derivatives as SOS1 inhibitors | SOS1, SOS2, RSU1 | HCAR2 3654/4885POLB 3799/4885NAPRT 1545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.